Overview

Health Canada now publishes and maintains a list of new drug submissions (NDS) that are currently under review—part of its transparency initiative to keep the public more informed about drug product review. Drugs will removed from the list once marketing approval is granted (via a Notice of Compliance (NOC)) or if the submission is withdrawn by the manufacturer. Currently the list only includes NDS filings but Health Canada has indicated that it will begin to post supplementary new drug submissions (SNDS) in the spring. 

The list is updated monthly and can be accessed here.